Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

A randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety, and tolerability of ML-004 in adolescents and adults with autism spectrum disorders (ASD).

ML-004 in ASD

Condition: Neurology
Phase: II
Clinicaltrials.gov ID: NCT05081245

What is the goal of the study?

Study objectives are to evaluate the safety and tolerability of ML-004 compared with placebo in subjects with ASD, and to evaluate efficacy of ML-004 compared with placebo in the improvement of social communication deficits in patients with ASD.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Gary Stobbe
Study Team Member: Theodore Ho, Theodore.Ho@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.